BVX Insider Trading

Insider Ownership Percentage: 31.92%
Insider Buying (Last 12 Months): £5,400
Insider Selling (Last 12 Months): GBX 0

BiVictriX Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at BiVictriX Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BiVictriX Therapeutics Share Price & Price History

Current Price: GBX 13
Price Change: +0.30 (1.20%)
As of 06/2/2023 08:39 PM ET

This chart shows the closing price history over time for BVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BiVictriX Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2022Iain Gladstone RossInsiderBuy30,000GBX 18£5,400
3/8/2022Iain Gladstone RossInsiderBuy100,000GBX 22£22,000
12/20/2021Tiffany Jane ThornInsiderBuy25,000GBX 26£6,500
11/4/2021Robert Edward HawkinsInsiderBuy20,000GBX 22£4,400
9/22/2021Iain Gladstone RossInsiderBuy43,507GBX 19£8,266.33
See Full Table

SEC Filings (Institutional Ownership Changes) for BiVictriX Therapeutics (LON:BVX)

38.16% of BiVictriX Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia. The company was formerly known as BiVictriX Plc and changed its name to BiVictriX Therapeutics Plc in August 2021. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
Read More on BiVictriX Therapeutics

Today's Range

Now: GBX 13
Low: 13
High: 13

50 Day Range

MA: GBX 14.41
Low: 12.25
High: 16

52 Week Range

Now: GBX 13
Low: 12.25
High: 23


645 shs

Average Volume

60,315 shs

Market Capitalization

£8.60 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of BiVictriX Therapeutics?

BiVictriX Therapeutics' top insider shareholders include:
  1. Iain Gladstone Ross (Insider)
  2. Robert Edward Hawkins (Insider)
  3. Tiffany Jane Thorn (Insider)
Learn More about top insider investors at BiVictriX Therapeutics.